Status:
WITHDRAWN
Remote EEG Device for Identification of Risk for Neonatal Seizures
Lead Sponsor:
Mayo Clinic
Conditions:
Neonatal Encephalopathy
Eligibility:
All Genders
Up to 30 years
Phase:
NA
Brief Summary
The purpose of this study is to see if the use of wireless brain wave monitoring can be helpful for newborns and help their medical providers identify seizures earlier and to monitor for the risk for ...
Detailed Description
Our goals are to evaluate the effectiveness of the Epilog device in identification of neonates who are at risk for seizures and need formal EEG monitoring or cooling. The current process for these pat...
Eligibility Criteria
Inclusion
- Age 28 days old or less (postnatal age)
- Neonatal encephalopathy as judged by clinical team or symptoms concerning for subtle seizures
- Patient currently in level 1 newborn nursery or level 2 or 3 NICU
Exclusion
- Medical comorbidity which would result in prolonged need for sedation
- Prolonged EEG monitoring is medically indicated
Key Trial Info
Start Date :
August 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 15 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05239585
Start Date
August 15 2024
End Date
August 15 2024
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905